Jeffrey K Aronson

Jeffrey K Aronson is a Consultant Physician and Clinical Pharmacologist affiliated with the University of Oxford, specifically within the Nuffield Department of Primary Care Health Sciences. His work spans clinical pharmacology, evidence-based medicine, and medical linguistics.

Key research interests:

• Classification and analysis of adverse drug reactions
• Systematic reviews and meta-analyses of pharmacological interventions
• Pharmacokinetics and pharmacodynamics modeling
• Philosophy of evidence-based medicine
• Linguistic aspects of medical and pharmacological terminology

Recent article trends: Focus on pharmaceutical supply chain challenges (stock-outs, overstocking), academic publishing ethics ("publish or perish" critiques), and evidence synthesis terminology.

Scientific awards and roles:

• President Emeritus of the British Pharmacological Society
• Honorary Fellow of the British Pharmacological Society and Faculty of Pharmaceutical Medicine
• Editor of Meyler’s Side Effects of Drugs and co-editor of Stephens’ Detection and Evaluation of Adverse Drug Reactions
• Former Member of the British National Formulary Advisory Board
• Chairman of the British Pharmacopoeia Commission’s Expert Advisory Group on Nomenclature

Teaching and policy contributions: He instructs medical students on therapeutics, contributes to textbooks, and has led systematic reviews on drug reactions and pharmacokinetic modeling.